Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Episode 41

0:00-1:00:16

Why haven’t we cured cancer yet? A Genentech scientist explains the real reason. In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Bob Liu, Senior Principal Scientist at Genentech Roche, to unpack one of the most important and misunderstood questions in modern medicine. This is a rigorous, scientifically grounded conversation on cancer biology, immunotherapy, and the real constraints shaping oncology drug development today. Dr. Liu brings over a decade of experience across antibody drug conjugates (ADCs), bispecific antibodies, and CAR-T therapies, offering a rare, insider perspective on why a universal cure remains elusive and where meaningful progress is actually being made. Thanks to our Founding Sponsor: LEUCENTRA: Helping teams evaluate, implement, and get real value from IT solutions that support innovation, not slow it down.

Publisher

BioTalk Unzipped

Link

biotalk-unzipped.captivate.fm/episode/why-havent-we-cured-cancer-immunotherapy-bob-liu

Published

March 19, 2026

Duration

1h

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Gregory Austin

BU

BioTalk Unzipped

@biotalkunzipped

#havent #curedcanceryet #bobliuexplains #lifesciences #medicine

The Nile